AspireAssist: A Low Risk Path to Weight Loss
October 26, 2016 · 0 commentsThe FDA recently approved a new non-surgical, low risk, reversible procedure for patient controlled weight loss. The new procedure is called AspireAssist. The AspireAssist Mechanism AspireAssist is an endoluminal weight loss device that induces weight loss in obese patients (BMI of 35-55). The device accomplishes weight loss by two mechanisms: reduction